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Abstract
Background: Percutaneous cholecystostomy (PC) can be used to treat patients with acute calculous
cholecystitis (ACC) who are considered to be unfit for surgery. However, this procedure has been
insufficiently investigated. This paper presents the results of a 10-year experience with this treatment
modality.
Methods: A retrospective observational study of all consecutive patients treated with PC for ACC in the
period from 1 May 2002 to 30 April 2012 was conducted. All data were collected from patients' medical
records.
Results: A total of 278 patients were treated with PC for ACC. Of these, 13 (4.7%) died within 30 days,
28 (10.1%) underwent early laparoscopic cholecystectomy and three (1.1%) patients were lost from
follow-up. Of the remaining 234 patients, 55 (23.5%) were readmitted for the recurrence of cholecystitis.
In 128 (54.7%) patients, PC was the definitive treatment (median follow-up time: 5 years), whereas 51
(21.8%) patients were treated with elective laparoscopic cholecystectomy. The frequency of recurrence of
cholecystitis in patients with contrast passage to the duodenum on cholangiography was lower than that
in patients without contrast passage (21.1% versus 36.7%; P = 0.037).
Conclusions: The present study, which is the largest ever conducted in this treatment area, supports the
hypothesis that PC is an effective treatment modality for critically ill patients with ACC unfit for surgery
and results in a low rate of 30-day mortality.
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Introduction
Acute cholecystitis is a common condition which occurs in up to
20% of all patients with symptomatic gallstone disease and is best
treated with early cholecystectomy.1 Generally, laparoscopic chol-
ecystectomy is the treatment of choice; it is considered to be
acceptable and safe, and is associated with low rates of morbidity
and mortality.2,3 However, conversion from laparoscopic to open
cholecystectomy substantially increases both morbidity and
mortality.4–6 The risk for conversion increases with the duration of
symptoms.7 In patients operated for acute calculous cholecystitis
(ACC), conversion is required in up to 25% of subjects.8
Thus, in patients with a prolonged duration of symptoms and
in critically ill patients who are considered to be unsuitable for
surgery, percutaneous cholecystostomy (PC), in which the gall-
bladder is drained without the need for general anaesthesia,9 can
be used as an alternative to laparoscopic cholecystectomy.10,11 Per-
cutaneous cholecystostomy can be considered either as a bridging
procedure to be followed by delayed laparoscopic cholecystec-
tomy, or as a definitive treatment option for patients considered
unfit for surgery.12–14
To date, only minor studies have evaluated the efficacy and
safety of PC in the treatment of ACC. This paper presents the
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results of a 10-year experience of the use of PC as a treatment
modality for ACC at a Danish university hospital.
Materials and methods
A retrospective study of outcomes in 278 consecutive patients
treated with PC for ACC at Aarhus University Hospital over the
10-year period from 1 May 2002 to 30 April 2012 was conducted.
The study was approved by the Danish Data Protection Agency
(ref. j.nr. 2007-58-0010).
Study population and data on patients
and procedures
Using the hospital’s patient administration data, 345 consecutive
patients treated with PC during the study period were identified
using the following procedure codes from The Danish Classifica-
tion of Surgical Procedures and Therapy: KJKA16 (percutaneous
gallbladder drainage); UXRD46 (cholangiography through a
catheter), and UXRD40 (cholangiography). From these 345
patients, all patients treated for indications other than ACC
(acalculous cholecystitis and disease of unknown pathogenesis)
were excluded, leaving a final study population of 278 patients.
All patients’ medical records were retrospectively reviewed to
obtain data on patient demographics, symptom duration, treat-
ment modality and outcome, cholecystectomy and other opera-
tions performed during the index admission, recurrence of
cholecystitis and 30-day mortality. All readmissions, both locally
and nationally, were recorded. Readmission data were accessed
through the Danish National Patient Registry, which includes
information on all hospital admissions from 1977 and all outpa-
tient clinic and emergency department visits from 1995 in
Denmark.15
Diagnosis and treatment algorithm
The diagnosis of ACC was based on the presence of abdominal
pain in the upper right quadrant, a positive Murphy’s sign, fever,
raised levels of C-reactive protein or leukocytes, and possibly
affected liver function tests. The clinical evaluation was sup-
plemented with ultrasonography or, rarely, computed tomogra-
phy (CT) imaging. The presence of gallstones and thickening
of the gallbladder wall (≥5 mm), probe tenderness and
pericholecystic fluid were regarded as radiological signs of ACC.16
Indications for PC included a high burden of comorbidity and
prolonged symptom duration (i.e. >5 days). Complicated symp-
tomatology (e.g. suspected cholangitis) prompted endoscopic
retrograde cholangiopancreaticography (ERCP) prior to PC.
Following PC, an antegrade cholangiography through the cath-
eter was performed on postoperative day 3 (PoD 3). If no passage
of contrast to the duodenum was shown, the procedure was
repeated on PoD 5. If contrast passed to the duodenum and the
patient’s clinical response was satisfactory, the catheter was
removed after 10 days of treatment. The presence of common bile
duct stones prompted an ERCP.
Technique of PC
Percutaneous cholecystostomy was performed under ultrasound
guidance by a dedicated interventional radiologist. The placement
of the catheter (i.e. transperitoneal or transhepatic approach)
varied according to the personal preference of the radiologist and
the availability of the gallbladder under the given circumstances.
The catheter was placed using an aseptic technique under local
anaesthesia. In the context of transhepatic placement, the gall-
bladder was always punctured using Seldinger’s technique and a
7-Fr pigtail catheter was placed in the gallbladder lumen. In the
context of transperitoneal placement, a one-step method using a
7-Fr pigtail catheter (Skater Single Step Drainage Z-Locking; PBN
Medicals Denmark A/S, Stenløse, Denmark) was used. The cath-
eter was fixed to the skin using a patch and flushed up to three
times daily.
Statistical analyses
Numerical data were described using the median and range as a
measure of variation and compared using a median test. Categori-
cal data were compared using Fisher’s exact test. When appropri-
ate, results are presented with 95% confidence intervals (CIs). Any
two-sided P-value of <0.05 was considered to indicate statistical
significance. All statistical analyses were carried out using stata
Version 13.0 (StataCorp LP, College Station, TX, USA).
Results
A total of 278 consecutive patients were treated with PC for ACC
at the study institution during the study period (Table 1). There
was no difference in demographic characteristics between patients
treated with the transperitoneal method and those treated with
the transhepatic approach (Table 2).
Complications
All complications related to the procedures were recorded
(Table 3). Catheter displacement was a frequent complication.
Table 1 Data on patient characteristics and treatment procedures in
278 patients treated with percutaneous cholecystostomy (PC) for
acute calculous cholecystitis
Characteristic Value
Age, years, median (range) 72.5 (21–99)
Gender, n (%)
Females 157 (56.5%)
Males 121 (43.5%)
Duration of symptoms, days, median (range)a 4 (1–70)
Duration of PC treatment, days, median (range)b 12 (0–193)
PC technique, n (%)
Transperitoneal 203 (73.0%)
Transhepatic 62 (22.3%)
Unknown 13 (4.7%)
aMissing values for 23 patients.
bMissing values for five patients.
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Not all catheters were replaced, mainly because the patient
in question demonstrated a good clinical response. No instance
of bleeding required surgical intervention. If cholascos was
suspected, an ultrasonography was performed. If cholascos was
verified, drains were placed percutaneously guided by ultrasonog-
raphy. There were no differences in complications between
patients treated with the transperitoneal and transhepatic
approaches, respectively.
Of the 278 patients treated with PC, 28 (10.1%) underwent
laparoscopic cholecystectomy during the index admission. Drains
in these patients were usually removed at surgery. The rate of
30-day mortality was 4.7% (13 patients). Three (1.1%) patients
were transferred to another hospital and were thus lost from
follow-up. The remaining 234 patients were discharged and con-
sidered to have been treated with PC for ACC (Fig. 1).
Disease recurrence and cholangiography
Of these 234 patients, 55 (23.5%) were readmitted for the recur-
rence of cholecystitis and treated accordingly (Table 4). Patients
with and without recurrence were similar in terms of median age,
symptom duration and duration of PC treatment (data not
shown). Among patients with recurrence of cholecystitis, a signifi-
cantly lower proportion was treated with a transhepatic approach
compared with patients without recurrence of cholecystitis (13.0%
versus 26.5%;P= 0.043) when missing values for mode of approach
were omitted. The median time from the end of the initial PC
treatment to readmission was 54.5 days (range: 0–1518 days).
In total, 128 patients (54.7%) were given PC as their definitive
treatment and were followed for a median duration of 5 years
(range: 1.1–10.5 years) without recurrence. Elective laparoscopic
cholecystectomy was subsequently performed in 51 (21.8%)
patients. In total, 215 patients underwent cholangiography during
the index admission (Fig. 2). The odds ratio for the recurrence of
cholecystitis was 2.17 (95% CI 1.02–4.55; P = 0.037) for patients
without contrast passage to the duodenum (36.7%) compared
with patients with contrast passage to the duodenum (21.1%) on
cholangiography.
Discussion
The incidence of gallstone disease, which is the primary risk factor
for ACC, increases with age.17,18 Although the reference standard
treatment of patients with ACC is laparoscopic cholecystectomy,
some patients, especially those with a prolonged duration of
symptoms and those who are critically ill, are considered to be
unfit for surgery. For these patients, PC, either as a bridging pro-
cedure to subsequent elective cholecystectomy or as a definitive
treatment modality, can be used in the management of ACC.10,11
The present study reports the results of a 10-year experience of
the use of PC as a treatment modality in 278 ACC patients who
Table 2 Data on patient characteristics and treatment procedures in 265 of 278 patients treated with percutaneous cholecystostomy for
acute calculous cholecystitis according to treatment approach (transperitoneal or transhepatic)a
Characteristic Transperitoneal (n = 203) Transhepatic (n = 62) P-value
Age, years, median (range) 73 (21–99) 71 (31–94) 0.135
Gender, male, n (%) 85 (41.9%) 27 (43.5%) 0.883
Duration of symptoms, days, median (range)b 4 (1–31) 5 (1–70) 0.184
Duration of PC treatment, days, median (range)c 12 (0–193) 11.5 (1–109) 0.918
Cholangiography performed, n (%) 180 (88.7%) 53 (85.5%) 0.508
Contrast passage to the duodenum, n (%) 126 (62.1%) 43 (69.4%) 0.365
aPatients for whom information on approach is missing are omitted (n = 13).
bMissing values for 22 patients.
cMissing values for five patients.
Table 3 Procedure-related complications according to treatment approach in 265 of 278 patients treated with percutaneous
cholecystostomy for acute calculous cholecystitisa
Complication Transperitoneal (n = 203) Transhepatic (n = 62) P-value
n (%) n (%)
Bile leak 10 (4.9%) 1 (1.6%) 0.467
Bleeding 2 (1.0%) 0 1.000
Catheter displaced, replaced 41 (20.2%) 10 (16.1%) 0.582
Catheter displaced, discontinued 19 (9.4%) 8 (12.9%) 0.472
Fistula to skin 4 (2.0%) 0 0.576
Abscess formation/infection 3 (1.5%) 0 1.000
aPatients for whom information on approach is missing are omitted (n = 13).
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were deemed unfit for laparoscopic cholecystectomy and thus
describes the largest series to be reported to date. The initial PC
served as a definitive treatment in 54.7% of patients and as a
bridging procedure to subsequent elective cholecystectomy in
21.8% of patients. The recurrence rate was 23.5%, which corre-
sponds to results by Sanjay et al.19
The present series demonstrated a 30-day mortality rate of
4.7%, which is lower than results presented by previous studies
with smaller populations.19,20 This discrepancy may be partially
explained by the fact that these earlier studies included patients
with both calculous and acalculous cholecystitis. As the latter
usually occurs in critically ill patients,21 the present population
may have had a lower burden of comorbidity, on which no infor-
mation was available, and thus a lower rate of mortality. However,
Sanjay et al.19 found no differences in need for intensive care or
frequency of readmission between patients with acalculous and
those with calculous cholecystitis.
In this hospital department, the vast majority of patients with
ACC are treated with either laparoscopic cholecystectomy or PC.
Only a minor proportion of patients are treated with antibiotics as
standalone therapy. The exact proportion of patients with ACC
who were treated with PC is unknown, but is estimated to be
approximately 12%. This accords with a study by Chang et al.,22
who found that 10.4% of their patients with ACC were treated
with PC. A retrospective study by Cherng et al.23 reported on 185
patients with ACC treated with PC, but did not indicate the total
number of patients diagnosed with ACC. Data from the study by
Chang et al.22 suggest that patients in the present series were com-
parable with those in the earlier study in terms of comorbidities.
The optimal time at which the catheter should be removed after
PC treatment for ACC remains controversial. Some authors advo-
cate a minimum treatment duration of 6 weeks,19 although Hsieh
et al.24 reported a higher risk for the early recurrence of cholecys-
titis if the placement of the catheter exceeded 2 weeks.24 In the
present study, the median interval between treatment and catheter
removal was 12 days, although there was a high degree of vari-
ation. Furthermore, it seems preferable to perform cholangio-
graphy through the PC catheter to ensure bile passage to the
duodenum before catheter removal, as recurrence rates were lower
in patients with contrast passage to the duodenum compared with
those without contrast passage. Therefore, in patients who do not
show passage to the duodenum on cholangiography, a lower
threshold for cholecystectomy should be considered.
Both the transperitoneal and transhepatic routes for PC have
been described in the literature, although the latter is more
common.19,25,26 However, Sanjay et al.19 suggested that the
transperitoneal route should be used when the gallbladder is
grossly distended and adherent to the abdominal wall, or when
unfavourable anatomy renders transhepatic access difficult. In the
present series, the transperitoneal approach was used more fre-
quently. Although there was no significant difference in the rate of
complications between the two routes, the frequency of compli-
cations in this series was higher than those reported in studies in
which the transhepatic approach was preferred.24,27,28
Furthermore, the transhepatic approach was found to be the
more effective option in the treatment of ACC in this study.
This finding may, of course, have occurred by chance, or it may
indicate that the position in which the catheter is placed is more
favourable with regard to gallbladder drainage in the transhepatic
approach because the catheter can be stabilized by the liver paren-
chyma. Other than the rate of recurrence of cholecystitis, which
Acute calculous
cholecystitis
(n = 278)
n = 234 
No recurrence
(n = 179)
Recurrence
(n = 55)
30-day mortality (n = 13)
Lost from follow-up (n = 3)
Early laparoscopic cholecystectomy (n = 28)
Delayed laparoscopic cholecystectomy
(n = 51)
Definitive treatment
(n = 128)
Figure 1 Flowchart of 278 patients treated with percutaneous
cholecystostomy for acute calculous cholecystitis
Table 4 Choice of treatment in recurrence of acute calculous chol-
ecystitis in 55 patients initially treated with percutaneous
cholecystostomy
Treatment modality n (%)
Percutaneous cholecystostomy 26 (47.3%)
Percutaneous cholecystostomy + laparoscopic
cholecystectomy
12 (21.8%)
Laparoscopic cholecystectomy 9 (16.4%)
Conservative 7 (12.7%)
Unknown 1 (1.8%)
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was found to be higher among patients treated with the
transperitoneal approach, no differences emerged in the charac-
teristics of patients assigned to the transhepatic and the trans-
peritoneal treatment modality, respectively. Thus, the transhepatic
route seems superior to the transperitoneal. To the present
authors’ knowledge, this study is the first to demonstrate a differ-
ence in recurrence rate between these two approaches.
The limitations of this study include its retrospective design
and thus a possible selection bias. In addition, the present data
provide no information on the severity of comorbidities in the
study patients, which limits possibilities for the comparison of
these data with those from other studies. However, the major
strengths of this study derive from the fact that the study popu-
lation is large in comparison with patient series in previous
work in this field, and from its longterm and almost complete
follow-up, which was facilitated by access to online Danish
medical registries.
In conclusion, the present study supports the suggestion that
PC is a feasible treatment modality for patients with ACC who are
deemed to be unfit for surgery. The rate of 30-day mortality in the
present series is low in comparison with those in previous studies.
In addition, the transhepatic route seems to be superior to the
transperitoneal route in avoiding the recurrence of cholecystitis.
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